Product
Supplier
Encyclopedia
Inquiry
Clindamycin-ECHEMI buy - large image1
Clindamycin-ECHEMI buy - image1

Clindamycin-ECHEMI

2 Inquiries

Unit Price: Get Latest Price
CAS No.:

18323-44-9

Port:

Any China Port

Packaging:

25 kgs/drum

Price valid (until):

2024-12-01

Company Type:
Distributor
Location:
China
Qualification:
Main Products:

API,Intermediate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Clindamycin is a lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria.

    Items Specifications
    Type Small Molecule
    Groups Approved, Vet approved
    Weight Average: 424.98
    Monoisotopic: 424.179871
    Chemical Formula C18H33ClN2O5S
    Indication

    In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci. Used topically, it is indicated for the treatment of acne vulgaris and is available in combination with benzoyl peroxide or tretinoinfor this purpose, or as a triple combination therapy with benzoyl peroxide and adapalene. Clindamycin is also indicated as a vaginal cream, suppository, or gel for the treatment of bacterial vaginosis in non-pregnant females.

    Clindamycin is used for antimicrobial prophylaxis against Viridans group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.

    Basic Info
    Product Name:

    Clindamycin

    Other Name:

    L-threo-α-D-galacto-Octopyranoside,methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-;L-threo-D-galacto-Octopyranoside,methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-,trans- α-;L-threo-α-D-galacto-Octopyranoside,methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-,(2S-trans)-;Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside;Clindamycin;Dalacin C;7-Chloro-7-deoxylincomycin;Clinimycin;7-Chlorolincomycin;Cleocin;7(S)-Chloro-7-deoxylincomycin;Sobelin;7-Deoxy-7(S)-chlorolincomycin;7-CDL;U 21251;Chlolincocin;Antirobe;Dalacine;Klimicin;ClindaDerm;Klindan 300;Dalacin V;Clincin;Clindam;13441-63-9;16669-21-9;24620-78-8;24696-19-3;1376624-06-4;1376758-11-0

    CAS No.:

    18323-44-9

    Molecular Formula:

    C18H33ClN2O5S

    InChIKeys:

    InChIKey=KDLRVYVGXIQJDK-AWPVFWJPSA-N

    Molecular Weight:

    424.98

    Exact Mass:

    424.98

    EC Number:

    242-209-1

    DSSTox ID:

    DTXSID2022836

    Color/Form:

    Yellow, amorphous solid

    ATC Code:

    D - Dermatologicals|G - Genito urinary system and sex hormones|J - Antiinfectives for systemic use

    Categories:

    Antibiotics

    Characteristics
    PSA:

    127.56000

    XLogP3:

    1.83

    Density:

    1.3±0.1 g/cm3

    Melting Point:

    141 - 143ºC

    Boiling Point:

    628.1±55.0 °C at 760 mmHg

    Flash Point:

    333.6±31.5 °C

    Refractive Index:

    1.574

    Water Solubility:

    >63.7 [ug/mL]|In water, 30.61 mg/L at 25 °C (est)

    Storage Conditions:

    Store in tight container as defined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity.|Commercially available clindamycin phosphate vaginal cream should be stored in a tight container at 20-25 °C; freezing should be avoided. The vaginal suppositories and clindamycin phosphate vaginal cream should be stored at a controlled room temperature of 25 °C, but may be exposed to temperatures ranging from 15-30 °C; exposure to temperatures exceeding 30 °C or high humidity should be avoided. When stored as recommended, the commercially available vaginal cream is stable for 18 months following the date of manufacture. /Clindamycin phosphate/|The commercially available gel containing clindamycin phosphate (clindamycin 1%) in fixed combination with benzoyl peroxide 5% should be refrigerated at 2-8 °C until dispensed.178 Once dispensed, the gel may be stored at a room temperature up to 25 °C for up to 60 days. The gel should not be frozen. /Clindamycin phosphate/|Commercially available clindamycin phosphate 1% topical gel, lotion, and solution should be stored in tight containers at 20-25 °C; freezing should be avoided. /Clindamycin phosphate/

    Vapor Pressure:

    5.28X10-17 mm Hg at 25 °C (est)

    Specific rotation:

    D +214° (chloroform)

    Henrys Law Constant:

    Henry's Law constant = 2.89X10-22 atm-cu m/mol at 25 °C (est)

    Dissociation Constants:

    Characteristic taste; odorless or has faint mercaptan-like odor; freely soluble in water, dimethylformamide, methanol; soluble in alcohol; practically insoluble in acetone; pKa: 7.72 in pure water /Clindamycin hydrochloride/

    Experimental Properties:

    Mol wt: 479.47. White crystals from ethanol-ethyl acetate, mp 141-143 °C. Specific optical rotation = +144 deg at 25 °C/D (water). pKa 7.6. Soluble in water, pyridine, ethanol, DMF /Clindamycin hydrochloride monohydrate/|Mol wt: 504.97. Soluble in water /Clindamycin 2-dihydrogen phosphate/

    Hazard Identification

    Classification of the substance or mixture

    Eye irritation, Category 2

    Reproductive toxicity, Additional category for effects on or via lactation

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H319 Causes serious eye irritation

    H362 May cause harm to breast-fed children

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P203 Obtain, read and follow all safety instructions before use.

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P263 Avoid contact during pregnancy and while nursing.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    P318 IF exposed or concerned, get medical advice.

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store in tight container as defined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity.

  • Seller Information
    Business Type:

    Distributor

    Main Products:

    API,Intermediate

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    30

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    201-300

    About Echemi Pharmaceutical 

    Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.

    5c54b7e7a92e19d38f90f7daf858e202.png

    Advantage for Pharmaceutical 

    • Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.

    • We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.

    • We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.

    2c0ca90da4086f3a1b7df867d79e8bba.png

    Product Category 

    We care for human and animal health and we are committed to creating a better social environment.

    •  Human API

    • Intermediate

    • Veterinary API

    • Agrochemical

    • Fine Chemical

    • Custom Synthesis



  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Clindamycin

    1 KG Oct 1, 2024
    India

    CLINDAMYCIN

    10 KG Feb 10, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.